Actinium Pharmaceuticals (ATNM) EBITDA (2012 - 2026)
Actinium Pharmaceuticals' EBITDA came in at $28 million for Q2 2026, compared with -$7.14 million a year earlier.
Powered by 
Analysis
Actinium Pharmaceuticals (ATNM) EBITDA (2012 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Actinium Pharmaceuticals reported EBITDA of $9.78 million; for FY2025, it came in at -$36.07 million.
- Going back by year, EBITDA was -$41.92 million in FY2024, -$51.71 million in FY2023, -$33.41 million in FY2022 and -$24.44 million in FY2021.
- The Q2 2026 figure represents the highest quarterly EBITDA in data going back to Q1 2012.
- Business Quant data shows ATNM's EBITDA at -$5.87 million (Q1 2026), -$6.86 million (Q4 2025) and -$5.49 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 9.10 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 8.33 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 999.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 5.09 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 4.63 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -9.70 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 5.89 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 1.30 Bn |
| 10 | Actinium Pharmaceuticals | 37.10 Mn | 37.10 Mn | - | 28.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 28.00 Mn |
| Mar 31, 2026 | -5.87 Mn |
| Dec 31, 2025 | -6.86 Mn |
| Sep 30, 2025 | -5.49 Mn |
| Jun 30, 2025 | -7.14 Mn |
| Mar 31, 2025 | -16.59 Mn |
| Dec 31, 2024 | -7.92 Mn |
| Sep 30, 2024 | -12.40 Mn |
| Jun 30, 2024 | -12.23 Mn |
| Mar 31, 2024 | -9.38 Mn |
| Dec 31, 2023 | -10.73 Mn |
| Sep 30, 2023 | -14.15 Mn |
| Jun 30, 2023 | -15.43 Mn |
| Mar 31, 2023 | -11.40 Mn |
| Dec 31, 2022 | -11.13 Mn |
| Sep 30, 2022 | -9.58 Mn |
| Jun 30, 2022 | -7.67 Mn |
| Mar 31, 2022 | -5.03 Mn |
| Dec 31, 2021 | -7.91 Mn |
| Sep 30, 2021 | -6.34 Mn |
API Access
Actinium Pharmaceuticals EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=ATNM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "ATNM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=ATNM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();